PNC Financial Services Group’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.43K Buy
1,956
+1,813
+1,268% +$8.59K ﹤0.01% 4256
2026
Q2
$651 Buy
143
+108
+309% +$429 ﹤0.01% 4928
2026
Q1
$140 Buy
35
+13
+59% +$64 ﹤0.01% 5073
2025
Q4
$154 Sell
22
-43
-66% -$241 ﹤0.01% 5012
2025
Q3
$302 Buy
+65
New +$304 ﹤0.01% 4889

Other funds holding TLSI

PNC Financial Services Group's TLSI Position: Q3 2026 in Review

PNC Financial Services Group increased its TriSalus Life Sciences (TLSI) stake by 1,268% in Q3 2026, buying an estimated $8.59K and bringing the position to 1,956 shares worth $8.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4256.

PNC Financial Services Group first reported a position in TLSI in Q3 2025 and has held it in 5 quarters since. 58 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • PNC Financial Services Group held 1,956 shares of TriSalus Life Sciences worth $8.43K as of Q3 2026.
  • PNC Financial Services Group bought 1,813 TriSalus Life Sciences shares in Q3 2026, an estimated $8.59K.
  • TriSalus Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4256 holding.
  • PNC Financial Services Group first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 5 quarters since.
  • 58 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.